Affordable Insulin Now Act
Rep. Craig Introduces Bill to Cap Monthly Insulin Costs at $35 for Private Insurance
The Affordable Insulin Now Act is currently in the early stages of the legislative process. It has been sent to three different House committees for review and is not yet scheduled for a vote. The bill is considered active as it moves through these initial committee assignments.
Legislative Progress
While insulin caps have broad public support and already exist for Medicare, extending these limits to the private insurance market often faces pushback in a divided Congress.
Key Points
Impact Analysis
Personal Impact
Life & Work
Small business owners who sponsor group health plans would be required to offer insulin at the capped cost-sharing rate. While this helps employees who use insulin, it could modestly increase premiums or plan costs for small employers, since insurers may shift the cost of lower copays into higher overall premiums. The impact depends on how insurers and PBMs adjust pricing.
“a group health plan or health insurance issuer offering group or individual health insurance coverage shall provide coverage of selected insulin products”
Programs
Disabilities
Milestones
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sent to a congressional committee for expert review. The committee decides whether this bill moves forward.
Introduced in House
The bill was officially filed and given a number. It now enters the legislative queue.
Votes
No votes have been recorded for this legislation yet.
Related News
2 articlesInsulin costs could be capped at $35 nationwide
A new bipartisan proposal in Congress, often referred to as the Affordable Insulin Now Act, aims to extend the $35 monthly cap to everyone, including those with private insurance. The plan builds on existing Medicare savings to expand relief to millions who currently pay far more out of pocket.
California to cap insulin costs at $35 a month for millions
Starting January 1, 2026, a new state law (SB 40) will cap insulin out-of-pocket costs at $35 for millions of privately insured Californians. The law bars insurers from requiring patients to meet deductibles before the cap kicks in, mirroring federal efforts to expand the Medicare cap.
Source Information
Document Type
Congressional Bill
Official Title
Affordable Insulin Now Act
Data Sources
Sponsor
Cosponsors
(6)Analysis generated by AI. Always verify with official sources.